Drugs Archives - Page 48 of 65

Podcast: KHN’s ‘What The Health?’ Congress And Health Care. Again.

In this episode of KHN’s “What the Health?” Julie Rovner of Kaiser Health News, Anna Edney of Bloomberg News, Alice Ollstein of Talking Points Memo and Kimberly Leonard of the Washington Examiner talk about the new push on health legislation by Republicans in the House, as well as developments on Medicaid work requirements, drug prices and the fate of children separated from their parents at the U.S.-Mexican border. Plus, for extra credit, the panelists offer their favorite health stories of the week.

July 26, 2018

Déjà Voodoo: Pharma’s Promises To Curb Drug Prices Have Been Heard Before

Several major drugmakers vow to contain drug prices, but similar pledges since the 1990s have not had much impact.

By Jay Hancock and Sarah Jane Tribble

July 25, 2018

Purdue Pharma Edits Public Service Ad In Washington Post

Did OxyContin maker admit opioids can be dangerous even when patients take them as prescribed — then walk it back?

By Fred Schulte

July 24, 2018

Must-Reads Of The Week From Brianna Labuskes

KHN’s newsletter editor, Brianna Labuskes, wades through hundreds of health articles from the week so you don’t have to.

By Brianna Labuskes

July 20, 2018

Podcast: KHN’s ‘What The Health?’ Drug Prices And Unicorns

In this episode of KHN’s “What the Health?” Julie Rovner of Kaiser Health News, Margot Sanger-Katz of The New York Times, Joanne Kenen of Politico, and Erin Mershon of Stat News discuss a series of health policy court decisions on everything from prescription drug discounts to soda taxes. Plus, Rovner, interviews health care futurist and consultant Jeff Goldsmith.

July 19, 2018

Staggering Prices Slow Insurers’ Coverage Of CAR-T Cancer Therapy

Some state Medicaid programs are not paying for the procedures, and Medicare’s complicated payment rates have hospitals concerned that it will not cover all the costs.

By Michelle Andrews

July 17, 2018

Must-Reads Of The Week From Brianna Labuskes

Newsletter editor Brianna Labuskes wades through hundreds of health articles from the week so you don’t have to.

By Brianna Labuskes

July 13, 2018

Podcast: KHN’s ‘What The Health?’ ACA Under Fire. Again.

In this episode of KHN’s “What the Health?” Julie Rovner of Kaiser Health News, Margot Sanger-Katz of The New York Times, Anna Edney of Bloomberg News and Julie Appleby of Kaiser Health News discuss the health politics of the latest Supreme Court pick, as well as the Trump administration’s efforts to further undermine the Affordable Care Act. Plus, for extra credit, the panelists recommend their favorite health stories of the week.

July 12, 2018

Can Insurers Use Genetic Testing Results? A Reader Wants To Know

Other readers ask what can be done to challenge unexpected medical bills — whether the result of an emergency room visit or after a change in prescription drug coverage.

By Michelle Andrews

July 10, 2018

State Prisons Fail To Offer Cure To 144,000 Inmates With Deadly Hepatitis C

A survey of 49 states reveals that an estimated 144,000 inmates with hepatitis C, a curable but potentially fatal disease, can’t get the expensive drugs they need to cure it.

By Siraphob Thanthong-Knight

July 9, 2018

Podcast: KHN’s ‘What The Health?’ Whither Work Requirements?

In this episode of KHN’s “What the Health?” Julie Rovner of Kaiser Health News, Joanne Kenen of Politico, Stephanie Armour of The Wall Street Journal and Anna Edney of Bloomberg News discuss the latest enrollment numbers for the Affordable Care Act, Medicaid work requirements in Kentucky and President Donald Trump’s proposed government reorganization plan. Plus, for extra credit, the panelists recommend their favorite health stories of the week.

July 5, 2018

Tennessee-Based Pain Management Group To Close Clinics Amid Financial Turmoil

The CEO of Comprehensive Pain Specialists was indicted in April. Now the group is closing clinics across several states.

By Fred Schulte

July 3, 2018

Out-Of-Pocket Costs Put HIV Prevention Drug Out Of Reach For Many At Risk

It’s getting increasingly difficult for patients to afford Truvada, also known as pre-exposure prophylaxis, or PrEP, because of the drug’s high price and insurance company efforts to restrict the use of coupons that shield patients from it.

By Shefali Luthra and Anna Gorman

July 3, 2018

Must-Reads Of The Week From Brianna Labuskes

KHN’s newsletter editor, Brianna Labuskes, wades through hundreds of health articles from the week so you don’t have to.

By Brianna Labuskes

June 29, 2018

Top Policy Expert’s Ties To Giant Drugmaker Often Go Unstated

Dr. Mark McClellan joined Johnson & Johnson’s board of directors after leaving the FDA, but the connection often isn’t mentioned in research papers or public events.

By Sarah Jane Tribble

June 29, 2018

Must-Reads Of The Week From Brianna Labuskes

Newsletter editor Brianna Labuskes, who reads everything on health care to compile our daily Morning Briefing, offers the best and most provocative stories for the weekend.

By Brianna Labuskes

June 22, 2018

Doling Out Pain Pills Post-Surgery: An Ingrown Toenail Not The Same As A Bypass

As the opioid epidemic rages, a Johns Hopkins surgeon and researcher is leading an effort to curb overprescribing by offering procedure-specific guidelines to ensure that post-surgical patients leave the hospital with enough, but not too much, pain medication.

By Julie Appleby

June 22, 2018

Purdue And The OxyContin Files

Purdue Pharma planned an extensive marketing campaign for the launch and promotion of the painkiller OxyContin. Here are Purdue’s internal budget documents from 1996 to 2002 — files released by the Florida attorney general’s office — that detail the company’s early strategy to sell and expand use of the drug.

June 13, 2018